Search results
The Dow closes 300 points higher and the S&P 500 looks to break a losing streak as investors wait...
Quartz· 1 day agoAs the day ended, the Dow Jones Industrial Average gained 322 points, 0.85%, to trade at 38,225. The...
Pfizer Embraces Direct-To-Consumer Model For Covid Antiviral, Says Comirnaty Revenues Continue To...
Benzinga via Yahoo Finance· 2 days agoThe company witnesses a significant decrease in Comirnaty and Paxlovid revenues globally and an...
President Biden, in Wilmington, NC, touts efforts to replace lead pipes in water systems
The News & Observer· 1 day agoDuring a Thursday visit to Wilmington, President Joe Biden touted $3 billion in newly released federal funding to help water utilities nationwide find and replace lead service lines. The Bipartisan ...
Don’t shred your noncompete yet | Philly Health Insider
Philly.com· 3 days agoThis week, we break down what a new FTC ban on employment noncompetes means in Philly. Plus, we look...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 2 days agoThe RS Rating measures a stock's 12-month running performance against all other stocks. That RS...
Pfizer lifts profit forecast as CEO sees reason for optimism in 2024
Reuters via AOL· 3 days ago(Reuters) -Pfizer lifted its annual earnings forecast on Wednesday and reported a first-quarter...
Hepatitis B is globally underassessed and undertreated, especially among women and Asian minorities...
Medical Xpress· 2 days agoNew evidence reveals global underassessment and undertreatment of chronic hepatitis B (HBV),...
Pfizer’s 44% Decline In Profits Still Tops Estimates—Stock Bounces From Decade Low
Forbes· 3 days agoThe company affirmed its full-year 2024 guidance of $58.5 billion to $61.5 billion in sales and...
REUTERS NEWS SCHEDULE AT 10:00 a.m. GMT/ 6:00 a.m. ET
Reuters via Yahoo Finance· 3 days agoInvestors will closely watch any changes to the drugmaker's 2024 forecast, especially for COVID-19 vaccine and antiviral treatment Paxlovid. Fcus will also be on the performance ...
Pfizer beats revenue estimates, raises profit outlook on cost cuts and strong non-Covid sales
CNBC· 3 days agoThe company now expects to book adjusted earnings of $2.15 to $2.35 per share for the fiscal year,...